trending Market Intelligence /marketintelligence/en/news-insights/trending/pe7KFXj72wsiT7-wP9AFyg2 content esgSubNav
In This List

Benitec Biopharma, NantWorks to collaborate on cancer program

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Benitec Biopharma, NantWorks to collaborate on cancer program

Benitec Biopharma Ltd. is in talks for a sub-license from Patrick Soon-Shiong's NantWorks to develop treatments for head and neck cancer using a gene silencing approach.

The company is negotiating terms of the collaboration with a targeted date for execution of Jan. 27, 2017.